Embold Therapeutics

Ownership

Private

Therapeutic Areas

Neurology

Stage

Preclinical

Modalities

Therapeutic enzymes

Embold Therapeutics General Information

Developing precision medicines for Parkinson's disease through therapeutic enzyme discovery. No clinical results reported in available sources.

Contact Information

Website

https://emboldtx.com/

Primary Industry

Biotech

Corporate Office

Redwood City, California
United States

Drug Pipeline

No pipeline data available

For full access to Embold Therapeutics's pipeline data

Key Partnerships

Not disclosed

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Embold Therapeutics Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

To view Embold Therapeutics's complete valuation and funding history, request access »

Embold Therapeutics Financial Metrics